Suppr超能文献

工艺和配方参数对聚乙烯吡咯烷酮VA 64热熔挤出物溶出度和稳定性特征的影响。

Influence of process and formulation parameters on dissolution and stability characteristics of Kollidon® VA 64 hot-melt extrudates.

作者信息

Maddineni Sindhuri, Battu Sunil Kumar, Morott Joe, Majumdar Soumyajit, Murthy S N, Repka Michael A

机构信息

Nektar Therapeutics, 455 Mission Bay Blvd S, San Francisco, California, 94158, USA.

出版信息

AAPS PharmSciTech. 2015 Apr;16(2):444-54. doi: 10.1208/s12249-014-0226-4. Epub 2014 Nov 1.

Abstract

The objective of the present study was to investigate the effects of processing variables and formulation factors on the characteristics of hot-melt extrudates containing a copolymer (Kollidon® VA 64). Nifedipine was used as a model drug in all of the extrudates. Differential scanning calorimetry (DSC) was utilized on the physical mixtures and melts of varying drug-polymer concentrations to study their miscibility. The drug-polymer binary mixtures were studied for powder flow, drug release, and physical and chemical stabilities. The effects of moisture absorption on the content uniformity of the extrudates were also studied. Processing the materials at lower barrel temperatures (115-135°C) and higher screw speeds (50-100 rpm) exhibited higher post-processing drug content (~99-100%). DSC and X-ray diffraction studies confirmed that melt extrusion of drug-polymer mixtures led to the formation of solid dispersions. Interestingly, the extrusion process also enhanced the powder flow characteristics, which occurred irrespective of the drug load (up to 40% w/w). Moreover, the content uniformity of the extrudates, unlike the physical mixtures, was not sensitive to the amount of moisture absorbed. The extrusion conditions did not influence drug release from the extrudates; however, release was greatly affected by the drug loading. Additionally, the drug release from the physical mixture of nifedipine-Kollidon® VA 64 was significantly different when compared to the corresponding extrudates (f2 = 36.70). The extrudates exhibited both physical and chemical stabilities throughout the period of study. Overall, hot-melt extrusion technology in combination with Kollidon® VA 64 produced extrudates capable of higher drug loading, with enhanced flow characteristics, and excellent stability.

摘要

本研究的目的是研究加工变量和配方因素对含共聚物(聚乙烯吡咯烷酮VA 64)的热熔挤出物特性的影响。在所有挤出物中均使用硝苯地平作为模型药物。利用差示扫描量热法(DSC)对不同药物 - 聚合物浓度的物理混合物和熔体进行研究,以考察它们的混溶性。对药物 - 聚合物二元混合物进行了粉末流动性、药物释放以及物理和化学稳定性研究。还研究了吸湿对挤出物含量均匀度的影响。在较低料筒温度(115 - 135°C)和较高螺杆转速(50 - 100转/分钟)下加工材料,后处理药物含量较高(约99 - 100%)。DSC和X射线衍射研究证实,药物 - 聚合物混合物的熔融挤出导致形成固体分散体。有趣的是,挤出过程还改善了粉末流动特性,这与药物负载量无关(高达40% w/w)。此外,与物理混合物不同,挤出物的含量均匀度对吸湿量不敏感。挤出条件不影响药物从挤出物中的释放;然而,释放受药物负载量的影响很大。此外,硝苯地平 - 聚乙烯吡咯烷酮VA 64物理混合物的药物释放与相应挤出物相比有显著差异(f2 = 36.70)。在整个研究期间,挤出物表现出物理和化学稳定性。总体而言,热熔挤出技术与聚乙烯吡咯烷酮VA 64相结合产生的挤出物能够实现更高的药物负载量,具有增强的流动特性和出色的稳定性。

相似文献

8
Crystal growth formation in melt extrudates.熔体挤出物中的晶体生长形成
Int J Pharm. 2007 Aug 16;341(1-2):162-72. doi: 10.1016/j.ijpharm.2007.04.008. Epub 2007 Apr 19.

引用本文的文献

7
Hot-Melt Extrusion: a Roadmap for Product Development.热熔挤出:产品开发路线图。
AAPS PharmSciTech. 2021 Jun 17;22(5):184. doi: 10.1208/s12249-021-02017-7.

本文引用的文献

2
Melt extrusion: process to product.熔融挤出:从工艺到产品。
Expert Opin Drug Deliv. 2012 Jan;9(1):105-25. doi: 10.1517/17425247.2012.642365. Epub 2011 Dec 6.
6
Applications of hot-melt extrusion for drug delivery.热熔挤出技术在药物递送中的应用。
Expert Opin Drug Deliv. 2008 Dec;5(12):1357-76. doi: 10.1517/17425240802583421.
10
Pharmaceutical applications of hot-melt extrusion: Part II.热熔挤出技术的药物应用:第二部分。
Drug Dev Ind Pharm. 2007 Oct;33(10):1043-57. doi: 10.1080/03639040701525627.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验